Decoding -cyclocitral-mediated retrograde signaling reveals the role of a detoxification response in plant tolerance to photooxidative stress
Adequate protein intake is essential when taking GLP-1 medications to preserve muscle mass during weight loss
Who is this not for
GLP-1 receptor agonists are prescription medicines originally developed to treat type 2 diabetes, and several are now also approved for weight management
How to Remain Global Surgery Billing Compliant in 2025 Checklist To prevent audit and denials, be sure your practice: Uses CPT 99024 consistently
Higher Risks of Gastrointestinal Effects in Diabetic Patients In October 2023, The Journal of the American Medical Association(JAMA), examined adverse events in patients with diabetes associated with GLP-1 RA in a research letter called Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss where it concluded that studies have found increased risks of gastrointestinal adverse events, such as biliary disease, pancreatitis, bowel obstruction, and gastroparesis